Fresh analysis reveals that patients who discontinue blockbuster slimming jabs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who end conventional lifestyle plans.
Research printed in a major health publication demonstrates that while obese individuals often shed substantial amounts of their total mass while on the medication, the weight is regained at an average rate of 0.8 kg per month after stopping.
"Individuals using these drugs should be cognizant of the danger of fast rebound weight gain when the treatment concludes," stated researcher Dr. Susan Jebb.
That rate of regain suggests a reversion to pre-treatment weight in about a year and a half.
Analyzing Approaches
The analysis, which examined dozens of studies involving thousands of participants, compared the outcomes of GLP-1 agonists with other pills.
Researchers note that individuals who shed pounds through lifestyle changes alone generally see a more gradual weight regain—approximately 0.1 kg a month—post-intervention.
The Reason for the Fast Regain
Doctors suggest the mode of action of the jabs is key to understanding the amplified weight return.
These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of the hormone levels far above than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and could reduce responsiveness to its actions," explained Dr. Adam Collins, a dietetics expert.
"Withdrawal of this hormone supplement means hunger is no longer kept in check, making overeating far more likely."
A Lifelong Condition?
The NHS advise the injections for people with obesity-related health risks, accompanied by recommended lifestyle changes.
Many experts say that, given the likelihood of weight regain, the therapy is often long-term.
This perspective is supported by pharmaceutical companies, who state that the findings "emphasize the long-term nature of obesity," similar to managing conditions like hypertension.
User Experiences
Users who have discontinued the jabs explain a sudden return of appetite.
"It was like a switch activating and I was suddenly extremely hungry," recalled an individual.
This challenge is exacerbated if patients have not adopted permanent lifestyle or habit modifications during treatment.
Widespread Interest
Figures suggest that a significant number of people in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Use is higher among females than males.
- The 40s and 50s demographic shows the highest level of interest.
- Many access the medications through private healthcare rather than the NHS.
In conclusion, researchers stress that while GLP-1 drugs are potent tools for shedding pounds, they are not a magic cure and lasting health benefits hinges on ongoing lifestyle support.
